| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.047 | 0.4 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |